TY - CHAP M1 - Book, Section TI - Absence Seizures A1 - Stannard, Karen M. A1 - Dlugos, Dennis J. A1 - Glauser, Tracy A2 - Sirven, Joseph I. A2 - Stern, John M. PY - 2011 T2 - Atlas of Video-EEG Monitoring AB - First described over 200 years ago by Tissot, childhood absence epilepsy (CAE) is a common pediatric epilepsy syndrome that affects otherwise normal children, with onset between ages 4 and 10 years and with a peak onset between 6 and 7 years.1–5 Commonly misperceived as a “benign” epilepsy syndrome, patients with CAE demonstrate variable response to therapy, exhibit cognitive deficits, encounter elevated rates of accidental injury, demonstrate long-term psychosocial difficulties, and have variable remission rates. Similar to other epilepsies, the current therapeutic approach for children with CAE is empiric: an antiepileptic drug (AED) is selected based on available data and clinical experience, then titrated to an acceptable balance of seizure control and side effects. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - neurology.mhmedical.com/content.aspx?aid=1103049241 ER -